{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:23:49Z","timestamp":1790429029096,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.urology.2021.06.010","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T05:57:56Z","timestamp":1624687076000},"page":"e40-e47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Priapism and Sickle Cell Disease: Special Considerations in Etiology, Management, and Prevention"],"prefix":"10.1016","volume":"156","author":[{"given":"Geeta","family":"Ahuja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwuka","family":"Ibecheozor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nnaemeka C.","family":"Okorie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish J.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela W.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R.","family":"Metwalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy B.","family":"Tonkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2021.06.010_bib0001","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.mcna.2016.09.009","article-title":"Sickle cell disease: a brief update","volume":"101","author":"Azar","year":"2017","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.urology.2021.06.010_bib0002","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2021.06.010_bib0003","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2021.06.010_bib0004","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1182\/bloodadvances.2018030619","article-title":"Metabolomic and molecular insights into sickle cell disease and innovative therapies","volume":"3","author":"Adebiyi","year":"2019","journal-title":"Blood advances"},{"key":"10.1016\/j.urology.2021.06.010_bib0005","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1743-6109.2009.01625.x","article-title":"Priapism: pathogenesis, epidemiology, and management","volume":"7","author":"Broderick","year":"2010","journal-title":"J. Sex. Med"},{"key":"10.1016\/j.urology.2021.06.010_bib0006","series-title":"Priapism in Boys and Men with Sickle Cell Disease - Demographics, Characteristics and Prevalence","author":"Rogers","year":"2009"},{"key":"10.1016\/j.urology.2021.06.010_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/297364","article-title":"Priapism in sickle cell anemia: emerging mechanistic understanding and better preventative strategies","volume":"2011","author":"Crane","year":"2011","journal-title":"Anemia"},{"key":"10.1016\/j.urology.2021.06.010_bib0008","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrurol.2011.28","article-title":"Priapism in hematological and coagulative disorders: An update","volume":"8","author":"Morrison","year":"2011","journal-title":"Nat. Rev. Urol"},{"key":"10.1016\/j.urology.2021.06.010_bib0009","first-page":"36","article-title":"Compartment syndrome","volume":"32","author":"Weinmann","year":"2003","journal-title":"Emerg Med Serv"},{"key":"10.1016\/j.urology.2021.06.010_bib0010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0022-5347(17)45549-2","article-title":"The ultrastructure of the erectile tissue in priapism","volume":"135","author":"Spycher","year":"1986","journal-title":"J Urol"},{"issue":"Suppl 5","key":"10.1016\/j.urology.2021.06.010_bib0011","first-page":"39","article-title":"Report of the american foundation for urologic disease (AFUD) thought leader panel for evaluation and treatment of priapism","volume":"13","author":"Berger","year":"2001","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2021.06.010_bib0012","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.sxmr.2018.10.007","article-title":"A systematic review on ischemic priapism and immediate implantation: do we need more data?","volume":"7","author":"Capece","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.urology.2021.06.010_bib0013","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/j.1464-410X.2008.07951.x","article-title":"The pharmacological management of intermittent priapismic states","volume":"102","author":"Chow","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2021.06.010_bib0014","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.ijir.3901251","article-title":"High-flow priapism (HFP) secondary to nesbit operation: management by percutaneous embolization and colour doppler-guided compression","volume":"17","author":"Liguori","year":"2005","journal-title":"Int J Impotence Res"},{"key":"10.1016\/j.urology.2021.06.010_bib0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.ijir.3901398","article-title":"High-flow priapism as a complication of a veno-occlusive priapism: Two case reports","volume":"18","author":"Rodr\u00edguez","year":"2006","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2021.06.010_bib0016","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1743-6109.2011.02317.x","article-title":"Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy","volume":"9","author":"Broderick","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2021.06.010_bib0017","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1259\/bjr\/62360925","article-title":"Priapism: pathophysiology and the role of the radiologist","volume":"85","author":"Halls","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.urology.2021.06.010_bib0018","first-page":"56","article-title":"Diagnostic and therapeutic options for the management of ischemic and nonischemic priapism","volume":"12","author":"Bassett","year":"2010","journal-title":"Rev. Urol"},{"key":"10.1016\/j.urology.2021.06.010_bib0019","first-page":"239","article-title":"Structure-function relations of human hemoglobins","volume":"19","author":"Marengo-Rowe","year":"2006","journal-title":"Proc. (Bayl. Univ. Med. Cent)"},{"key":"10.1016\/j.urology.2021.06.010_bib0020","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2021.06.010_bib0021","series-title":"StatPearls","article-title":"Sickle cell disease","author":"Sedrak","year":"2021"},{"issue":"6","key":"10.1016\/j.urology.2021.06.010_bib0022","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/00000658-191412000-00004","article-title":"Priapism: Report of cases and a clinical study of the literature with reference to its pathogenesis and surgical treatment","volume":"60","author":"Hinman","year":"1914","journal-title":"Ann Surg"},{"key":"10.1016\/j.urology.2021.06.010_bib0023","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0008-6363(99)00135-2","article-title":"Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease?","volume":"43","author":"Sullivan","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.urology.2021.06.010_bib0024","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ewjm.175.3.193","article-title":"Methemoglobinemia","volume":"175","author":"Rehman","year":"2001","journal-title":"West J Med"},{"key":"10.1016\/j.urology.2021.06.010_bib0025","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.urology.2021.06.010_bib0026","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/archinte.1980.00330220022011","article-title":"Priapism and impotence in homozygous sickle cell disease","volume":"140","author":"Emond","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.urology.2021.06.010_bib0027","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0022-5347(17)58497-9","article-title":"Priapism: evolution of management in 48 patients in a 22-year series","volume":"117","author":"Nelson","year":"1977","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.06.010_bib0028","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1464-410X.2002.03022.x","article-title":"Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study","volume":"90","author":"Adeyoju","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2021.06.010_bib0029","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1743-6109.2008.00770.x","article-title":"Sickle cell disease status and outcomes of african-american men presenting with priapism","volume":"5","author":"Bennett","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2021.06.010_bib0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ajh.20642","article-title":"Cerebrovascular disease associated with sickle cell pulmonary hypertension","volume":"81","author":"Kato","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.urology.2021.06.010_bib0031","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.ju.0000087608.07371.ca","article-title":"American urological association guideline on the management of priapism","volume":"170","author":"Montague Drogo","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.06.010_bib0032","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1182\/blood-2014-09-551887","article-title":"How I treat priapism","volume":"125","author":"Anele","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.urology.2021.06.010_bib0033","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1743-6109.2005.20235.x","article-title":"Intracavernosal irrigation by cold saline as a simple method of treating iatrogenic prolonged erection","volume":"2","author":"Ateyah","year":"2005","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2021.06.010_bib0034","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4111\/kju.2013.54.6.394","article-title":"Transient distal penile corporoglanular shunt as an adjunct to aspiration and irrigation procedures in the treatment of early ischemic priapism","volume":"54","author":"Canguven","year":"2013","journal-title":"Korean J Urol"},{"key":"10.1016\/j.urology.2021.06.010_bib0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpurol.2013.07.024","article-title":"Priapism in children: a comprehensive review and clinical guideline","volume":"10","author":"Donaldson","year":"2014","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.urology.2021.06.010_bib0036","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.juro.2012.08.245","article-title":"Corporal burnett \"snake\" surgical maneuver for the treatment of ischemic priapism: Long-term followup","volume":"189","author":"Segal","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.06.010_bib0037","first-page":"316","article-title":"Should perioperative anticoagulation be an integral part of the priapism shunting procedure?","volume":"2","author":"Lue","year":"2013","journal-title":"Transl. Androl. Urol"},{"key":"10.1016\/j.urology.2021.06.010_bib0038","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bju.15127","article-title":"Favourable multi-institutional experience with penoscrotal decompression for prolonged ischaemic priapism","volume":"126","author":"Baumgarten","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2021.06.010_bib0039","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5534\/wjmh.17040","article-title":"Role of penile prosthesis in priapism: a review","volume":"36","author":"Reddy","year":"2018","journal-title":"World J Mens Health"},{"key":"10.1016\/j.urology.2021.06.010_bib0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000474145","article-title":"Priapism in sickle cell disease: the case for early implantation of the penile prosthesis","volume":"30","author":"Monga","year":"1996","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.06.010_bib0041","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0090-4295(01)01492-3","article-title":"Antiandrogens in the treatment of priapism","volume":"59","author":"Dahm","year":"2002","journal-title":"Urology"},{"issue":"2 Pt 1","key":"10.1016\/j.urology.2021.06.010_bib0042","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0022-5347(17)35520-9","article-title":"Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism","volume":"150","author":"Levine","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.06.010_bib0043","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00005392-199501000-00054","article-title":"Management of recurrent priapism with epinephrine self-injection and gonadotropin-releasing hormone analogue","volume":"153","author":"Steinberg","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.06.010_bib0044","first-page":"167","article-title":"Successful treatment of stutter priapism with an antiandrogen","volume":"4","author":"Costabile","year":"1998","journal-title":"Tech Urol"},{"key":"10.1016\/j.urology.2021.06.010_bib0045","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.urology.2004.02.005","article-title":"Idiopathic stuttering priapism: recovery of detumescence mechanism with temporal use of antiandrogen","volume":"63","author":"Yamashita","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.urology.2021.06.010_bib0046","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004198.pub2","article-title":"Treatments for priapism in boys and men with sickle cell disease","volume":"9","author":"Chinegwundoh","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.urology.2021.06.010_bib0047","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.urology.2004.12.003","article-title":"Intracavernosal etilefrine self-injection therapy for recurrent priapism: one decade of follow-up","volume":"65","author":"Teloken","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2021.06.010_bib0048","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0090-4295(96)00027-1","article-title":"Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine","volume":"47","author":"Virag","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.urology.2021.06.010_bib0049","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1046\/j.1365-2141.2002.03691.x","article-title":"Etilefrine for the prevention of priapism in adult sickle cell disease","volume":"118","author":"Okpala","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.urology.2021.06.010_bib0050","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjmed.2014.03.019","article-title":"Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease","volume":"127","author":"Burnett","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.urology.2021.06.010_bib0051","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.ijir.3901165","article-title":"Gabapentin in the management of the recurrent, refractory, idiopathic priapism","volume":"16","author":"Perimenis","year":"2004","journal-title":"Int J Impotence Res"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429521005537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429521005537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:54:40Z","timestamp":1758768880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429521005537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":51,"alternative-id":["S0090429521005537"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2021.06.010","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Priapism and Sickle Cell Disease: Special Considerations in Etiology, Management, and Prevention","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2021.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}